Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates adding TRC102 to standard chemotherapy with pemetrexed plus cisplatin or carboplatin during radiation therapy for stage II…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Large Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• TRC102

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Adenocarcinoma, Lung Large Cell Carcinoma | Phase 2 | Status: RECRUITING